Abstract

Osteoporosis is a genetic disease characterized by progressive reductions in bone mineral density (BMD) leading to an increased risk of fracture. Over the last decade, genome-wide association studies (GWASs) have identified over 1000 associations for BMD. However, as a phenotype BMD is challenging as bone is a multicellular tissue affected by both local and systemic physiology. Here, we focused on a single component of BMD, osteoblast-mediated bone formation in mice, and identified associations influencing osteoblast activity on mouse Chromosomes (Chrs) 1, 4, and 17. The locus on Chr. 4 was in an intergenic region between Wnt4 and Zbtb40, homologous to a locus for BMD in humans. We tested both Wnt4 and Zbtb40 for a role in osteoblast activity and BMD. Knockdown of Zbtb40, but not Wnt4, in osteoblasts drastically reduced mineralization. Additionally, loss-of-function mouse models for both genes exhibited reduced BMD. Our results highlight that investigating the genetic basis of in vitro osteoblast mineralization can be used to identify genes impacting bone formation and BMD.

Highlights

  • Osteoporosis is a metabolic disease characterized by progressive bone loss leading to skeletal fragility and fracture [1]

  • Osteoporosis is a common disease strongly influenced by genetics

  • We conducted a genome wide association study (GWAS) using the ability of the osteoblast to make bone-like mineralized nodules in vitro as a simpler phenotype to find genes that have a robust impact on bone

Read more

Summary

Introduction

Osteoporosis is a metabolic disease characterized by progressive bone loss leading to skeletal fragility and fracture [1]. 200 million people worldwide have or are at risk of developing osteoporosis [2], leading to ~8.6 million fractures annually [3]. As the proportion of aged persons worldwide is increasing, osteoporosis is becoming an even greater public health burden [4]. History remains the strongest risk factor for development of osteoporosis and studies in animal models reinforce that this is a complex genetic disease [8,9,10]. Increasing our understanding of the genes influencing osteoporosis is critical for the development of approaches for its treatment and prevention

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.